Biomedicine Discovery Institute to collaborate with Yale University

Yale's School of Medicine

The Biomedicine Discovery Institute has signed a Memorandum of Understanding (MoU) with one of the oldest universities in the US, Yale. The MoU will allow for greater collaboration with Yale's program in Integrative Cell Signaling and Neurobiology of Metabolism (ICSNM), and will enhance the exchange of staff, students and resources between the two institutions.

Head of the BDI's Metabolic Disease and Obesity Program, Professor Tony Tiganis, led a delegation to Yale in June to help establish the strategic alliance with Yale. Professor Tiganis said the alliance would fast-track quality research, particularly in the fight to tackle obesity and type 2 diabetes.

“Our two programs have overlapping and complementary research interests, and this alliance will help us to address some of the fundamental research questions in the area of metabolic research,” Professor Tiganis said.

“Our collaboration will fast-track research endeavours and help translate our research from discoveries to the clinic, which will help combat the epidemics of obesity and type 2 diabetes,” he said.